Literature DB >> 11145040

Differential expression of matrix metalloproteinases in labial salivary glands of patients with primary Sjögren's syndrome.

P Pérez1, E Goicovich, C Alliende, S Aguilera, C Leyton, C Molina, R Pinto, R Romo, B Martinez, M J González.   

Abstract

OBJECTIVE: To determine the enzymatic activity and cellular localization of matrix metalloproteinases (MMPs) 2, 3, and 9 in labial salivary glands from patients with different degrees of severity of primary Sjogren's syndrome (primary SS).
METHODS: Gelatinase activity was determined by zymography and quantified by densitometry. The specificity of MMPs was determined using protease inhibitors and chelators, as well as activators of the latent forms of these enzymes. The cellular localization of MMPs was carried out using monoclonal antibodies that recognize their latent and active forms.
RESULTS: Labial glands from control subjects and patients showed gelatinase activity for MMP-2 and MMP-9. Activation studies revealed that both enzymes were predominantly present in their latent forms. The highest levels of MMP-9 activity were detected in patients with severe, active, primary SS (except for patients with severe clinical symptoms for extended periods) and correlated with structural and functional glandular changes. MMP-2 activity was almost the same in patients and controls. MMPs were detected by immunolocalization only in acinar and ductal cells and were homogeneously distributed throughout patients' glands. MMP-2 and MMP-9 expression paralleled their gelatinase activity. MMP-3, detectable only with immunologic methods, was absent in control subjects but abundantly expressed in patients. Importantly, MMP protein levels in acinar and ductal cells were independent of either the presence or the proximity of mononuclear infiltrate cells.
CONCLUSION: MMP-3 and MMP-9 expression, as well as MMP-9 catalytic activity, were increased in tissue samples from SS patients in a manner that correlated with the severity of the disease. Most important, increased MMP activity stemmed from exocrine epithelial cells and was not due to infiltrating lymphocytes. Thus, changes in salivary glands as a consequence of proteolysis may lead to severe glandular destruction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11145040     DOI: 10.1002/1529-0131(200012)43:12<2807::AID-ANR22>3.0.CO;2-M

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  19 in total

1.  Basal lamina disorganisation of the acini and ducts of labial salivary glands from patients with Sjogren's syndrome: association with mononuclear cell infiltration.

Authors:  C Molina; C Alliende; S Aguilera; Y-J Kwon; L Leyton; B Martínez; C Leyton; P Pérez; M-J González
Journal:  Ann Rheum Dis       Date:  2005-07-13       Impact factor: 19.103

Review 2.  Animal models of Sjögren's syndrome.

Authors:  Malin V Jonsson; Nicolas Delaleu; Roland Jonsson
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

Review 3.  Autoimmunity in the pathogenesis and treatment of keratoconjunctivitis sicca.

Authors:  Katy C Liu; Kyle Huynh; Joseph Grubbs; Richard M Davis
Journal:  Curr Allergy Asthma Rep       Date:  2014-01       Impact factor: 4.806

4.  Encapsulation of primary salivary gland cells in enzymatically degradable poly(ethylene glycol) hydrogels promotes acinar cell characteristics.

Authors:  Andrew D Shubin; Timothy J Felong; Brittany E Schutrum; Debria S L Joe; Catherine E Ovitt; Danielle S W Benoit
Journal:  Acta Biomater       Date:  2016-12-27       Impact factor: 8.947

Review 5.  Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome.

Authors:  Michael Voulgarelis; Athanasios G Tzioufas
Journal:  Nat Rev Rheumatol       Date:  2010-08-03       Impact factor: 20.543

6.  Epigenetics in systemic lupus erythematosus: leading the way for specific therapeutic agents.

Authors:  Matlock A Jeffries; Amr H Sawalha
Journal:  Int J Clin Rheumtol       Date:  2011-08

Review 7.  Autoimmune disease in the epigenetic era: how has epigenetics changed our understanding of disease and how can we expect the field to evolve?

Authors:  Matlock A Jeffries; Amr H Sawalha
Journal:  Expert Rev Clin Immunol       Date:  2015-01       Impact factor: 4.473

Review 8.  Matrix metalloproteinase-9 and autoimmune diseases.

Authors:  Maya Ram; Yaniv Sherer; Yehuda Shoenfeld
Journal:  J Clin Immunol       Date:  2006-05-02       Impact factor: 8.317

9.  Lymphocytic infiltration leads to degradation of lacrimal gland extracellular matrix structures in NOD mice exhibiting a Sjögren's syndrome-like exocrinopathy.

Authors:  Katja Schenke-Layland; Jiansong Xie; Mattias Magnusson; Ekaterini Angelis; Xiaodong Li; Kaijin Wu; Dieter P Reinhardt; W Robb Maclellan; Sarah F Hamm-Alvarez
Journal:  Exp Eye Res       Date:  2009-10-21       Impact factor: 3.467

Review 10.  Non-invasive multiphoton imaging of extracellular matrix structures.

Authors:  Katja Schenke-Layland
Journal:  J Biophotonics       Date:  2008-12       Impact factor: 3.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.